Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.
Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.
Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.
If left untreated, TTTS can have devastating consequences. Medical research indicates that:
TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.
Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.
Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.
Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:
Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.
Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.
Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.
According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.
When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.
Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.
Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."
Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.
Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.
The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.
Credit: AI
The US Department of Health and Human Services (HHS) has decertified Network for Hope, the federally funded organ procurement organization (OPO), which serves Kentucky and parts of Ohio, and West Virginia.
HHS officials cited "persistent safety failures" that could undermine public trust in organ transplantation as the reason for their move.
The move comes after months-long federal investigation into cases where organ recovery procedures were initiated despite patients showing signs of life.
The announcement marks one of the most significant federal actions against an organ procurement organization in recent years. It comes amid a bigger overhaul of the US organ transplant system.
"We're taking action because one bad apple can undermine trust in the entire transplant system," US Health Secretary Robert F. Kennedy Jr. said while announcing the proposed decertification, adding that patient safety and trust must remain the highest priority.
The investigation stems from a widely reported 2021 case involving a Kentucky man who was being evaluated for organ donation after a drug overdose.
According to federal officials, preparations for organ retrieval continued even though the patient reportedly began showing neurological signs suggesting he was regaining consciousness. The procedure was ultimately halted, and the man survived.
Following that incident, the Health Resources and Services Administration (HRSA) reviewed 351 cases in which organ donation had been authorized but not completed.
Also read: Dr. Erica Schwartz Confirmed As CDC’s First Permanent Director In Nearly A Year
Federal investigators found:
Investigators also pointed out ineffective neurological examinations, inadequate coordination between hospitals and procurement teams, questionable consent practices, and inconsistencies and errors in determining causes of death, particularly in cases of deaths due to overdose.
Network for Hope has rejected the allegations and said it plans to appeal the proposed decertification.
In a statement, the organization said it "strongly disagrees" with the decision and maintains that it follows federal policies governing organ donation.
It also said that it has already introduced additional safeguards and strict policies, including instructing staff to stop organ donation procedures if ethical and legal concerns arise.
Most importantly, OPOs have no authority to declare death. That decision is made independently by hospital physicians before any organ recovery process can begin.
Most organ donations occur after brain death or circulatory death under strict medical protocols.
Earlier investigations into the Kentucky cases caused led to removing themselves from organ donor registries, raising concerns that safety controversies could reduce the availability of organs for patients awaiting transplantation.
Currently, more than 100,000 Americans are currently waiting for a life-saving organ transplant, with kidneys accounting for the majority of the demand. While organ donation remains one of the most effective ways to save lives, public confidence is essential to keeping donor registrations high.
Credit: AI
The U.S. Senate has confirmed Dr. Erica Schwartz as the next Director of the U.S. Centers for Disease Control and Prevention (CDC), making her the public health agency's first permanent leader in nearly a year after months of uncertainty. The Senate approved her nomination in a 51-44 vote on August 5.
President Donald Trump nominated Schwartz in April, calling her "incredibly talented." During her confirmation hearing, she pledged to lead the CDC with transparency and scientific integrity.
She succeeds acting CDC Director Dr. Jay Bhattacharya, who had been leading the agency since February.
"I will lead with transparency, scientific integrity and accountability," Schwartz told senators during her confirmation hearing.
Schwartz, a physician, lawyer and former U.S. Deputy Surgeon General has an extensive background in medicine.
She takes charge of the CDC at a time when it is battling multiple outbreaks, staff shortages and growing scrutiny and uncertainty over its scientific independence.
The agency has also undergone major workforce reductions while responding to several public health challenges, including a resurgence of measles, foodborne illness outbreaks and international infectious disease threats.
Schwartz's appointment is expected to bring stability to an agency that plays a central role in tracking disease outbreaks, issuing vaccination recommendations, responding to health emergencies and guiding public health policy in the US.
Also read: US Measles Cases Reach 2,371; RFK Jr Takes U-Turn, Urges Families to Vaccinate Kids
Schwartz obtained her medical degree from Brown University and also holds a Master of Public Health and a law degree. She served in the U.S. Navy before joining the U.S. Public Health Service, where she later became Deputy Surgeon General during President Trump's first administration.
She has also served as Chief Medical Officer of the U.S. Coast Guard and most recently held leadership positions in the private healthcare sector.
Her confirmation comes as public health experts closely watch how the CDC balances scientific decision-making with increasing political scrutiny.
Many believe her appointment will be critical in rebuilding confidence in one of the world's most influential public health agencies.
Also read: One In Three Hospital Patients With Serious Mould Infections Died, CDC Study Finds
Dr. Erica Schwartz is President Donald Trump's third CDC nominee in less than two years.
Schwartz ha pledged to restore public trust in the CDC through transparency and evidence-based decision-making during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions (HELP).
Throughout her nomination hearing, Schwartz repeatedly expressed support for vaccines, including mRNA COVID-19 vaccines, and strongly endorsed vitamin K injections for newborns to prevent life-threatening bleeding.
Although she also acknowledged that scientific evidence does not support that vaccines cause autism, she argued that more research is needed to better understand the rising cases of autism.
"We owe it to the American people to figure out why one in 30 children now has autism," she said.
Schwartz stated that she did not believe either President Trump or Health Secretary Kennedy would ask her to take actions that would harm public health or violate the law.
Credit: iStock
Amid rising global infertility rates, a new study has found that an imbalance in the bacteria present in men's semen may reduce a couple's chances of having a baby and increase the risk of pregnancy loss. Researchers also found that the composition of women's gut bacteria may influence fertility outcomes.
The study, published in The Lancet Obstetrics, Gynaecology & Women's Health, found these associations were particularly evident among couples undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), as well as those with a history of recurrent pregnancy loss.
Researchers from the University of Copenhagen, Denmark, said the findings point to "imbalances in men's semen and in women's gut bacteria as previously overlooked and potentially treatable risk factors for infertility and recurrent pregnancy loss."
Although the vaginal microbiome has been studied extensively in relation to fertility, the gut and seminal microbiomes have been largely overlooked.
“Incorporation of couple-level microbial assessment might represent a novel approach for targeted therapeutic strategies,” the team said.
The researchers followed 353 women and 191 of their male partners between April 2018 and September 2023. All participants were heterosexual couples undergoing fertility treatment or had experienced recurrent pregnancy loss.
They analyzed bacterial communities in the women's gut and vagina and in the men's semen before tracking pregnancies and birth outcomes. About one in four men had an unhealthy bacterial imbalance, known as dysbiosis, in their semen.
Among couples undergoing IVF or ICSI:
The researchers also noted that standard semen analysis cannot detect this bacterial imbalance, meaning a man's test results may appear normal even when dysbiosis is present.
The study found that an imbalance in women's gut bacteria was associated with:
However, gut bacterial imbalance was not associated with miscarriage, while an imbalance in vaginal bacteria showed no clear link with either infertility or pregnancy loss.
According to the researchers, assessing the microbiome in both men and women could improve infertility evaluation and help identify previously overlooked, potentially treatable factors affecting fertility.
They added that, if confirmed in larger studies, therapies aimed at restoring healthy bacterial balance in semen and the gut could improve fertility outcomes and reduce recurrent pregnancy loss.
Infertility is a disease of the male or female reproductive system, defined as the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse.
According to the World Health Organization (WHO), one in six people globally experience infertility during their lifetime. The condition can cause significant emotional distress, social stigma and financial hardship, with far-reaching effects on mental and psychosocial well-being.
© 2024 Bennett, Coleman & Company Limited